Literature DB >> 23687588

Making ERCP training safe: A protocol-based strategy to minimize complications during selective biliary cannulation.

Boon Eu Andrew Kwek1, Tiing Leong Ang, Eng Kiong Teo, Kwong Ming Fock.   

Abstract

BACKGROUND AND AIMS: Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced procedure with significant complication rate of 5 to 10%. Scant data is available on quality indicators for trainee-involved ERCP. In our study, we evaluated the outcome of trainee-involved ERCPs in which a protocol-based strategy to minimize complications during selective biliary cannulation was adopted. PATIENTS AND METHODS: Hands-on training was excluded if patients had ASA grade > 3. The trainee's attempts at selective biliary cannulation were stopped and the procedure taken over by the supervising expert endoscopist if the following factors were encountered: (1) failed cannulation after 5 attempts; (2) unsuccessful cannulation after 10 minutes; (3) edematous papilla; (4) pancreatic duct cannulation ≥ 2 times. After successful ductal cannulation, the trainee was allowed to continue additional hands on training in other aspects such as stone extraction and stenting.
RESULTS: During the study period, 331 patients underwent ERCP. Trainee group (TG) consisted of 85 patients; mean age 70 (range 27-99). Expert group (EG) consisted of 246 patients; mean age 65 (range 19-98). The overall technical success rate was 97.9% and there was no significant difference between TG (98.8%) and EG (97.6%). The overall complication rate was 3.9% and there was no difference between TG (3.5%) and EG (4%). In TG, although inadvertent pancreatic duct cannulation occurred in 12/85 (14.1%), acute pancreatitis developed only in 3/85 (3.5%).
CONCLUSION: The high success and low complication rates in trainee-involved and expert-only ERCP procedures were similar. While using a protocol-based strategy, good clinical outcome during the provision of hands-on training for ERCP was observed.

Entities:  

Keywords:  cholangiopancreatography; education; endoscopic retrograde; quality

Year:  2012        PMID: 23687588      PMCID: PMC3655343          DOI: 10.4161/jig.22199

Source DB:  PubMed          Journal:  J Interv Gastroenterol        ISSN: 2154-1280


  11 in total

Review 1.  Adverse outcomes of ERCP.

Authors:  Martin L Freeman
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

2.  Guideline on training and credentialing in endoscopic retrograde cholangiopancreatography.

Authors:  T L Ang; J Cheng; J L C Khor; S J Mesenas; K F C Vu; W K Wong
Journal:  Singapore Med J       Date:  2011-09       Impact factor: 1.858

Review 3.  Endoscopic sphincterotomy complications and their management: an attempt at consensus.

Authors:  P B Cotton; G Lehman; J Vennes; J E Geenen; R C Russell; W C Meyers; C Liguory; N Nickl
Journal:  Gastrointest Endosc       Date:  1991 May-Jun       Impact factor: 9.427

4.  European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.

Authors:  J-M Dumonceau; A Andriulli; J Deviere; A Mariani; J Rigaux; T H Baron; P A Testoni
Journal:  Endoscopy       Date:  2010-05-26       Impact factor: 10.093

Review 5.  Quality indicators for endoscopic retrograde cholangiopancreatography.

Authors:  Todd H Baron; Bret T Petersen; Klaus Mergener; Amitabh Chak; Jonathan Cohen; Stephen E Deal; Brenda Hoffman; Brian C Jacobson; John L Petrini; Michael A Safdi; Douglas O Faigel; Irving M Pike
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

6.  Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice.

Authors:  Earl J Williams; Steve Taylor; Peter Fairclough; Adrian Hamlyn; Richard F Logan; Derrick Martin; Stuart A Riley; Peter Veitch; Mark Wilkinson; Paula R Williamson; Martin Lombard
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

Review 7.  Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.

Authors:  Wence Zhou; Yumin Li; Quanbao Zhang; Xun Li; Wenbo Meng; Lei Zhang; Hui Zhang; Kexiang Zhu; Xiaoliang Zhu
Journal:  Pancreatology       Date:  2011-08-31       Impact factor: 3.996

8.  A simple way of avoiding post-ERCP pancreatitis.

Authors:  Fausto Lella; Francesco Bagnolo; Elena Colombo; Umberto Bonassi
Journal:  Gastrointest Endosc       Date:  2004-06       Impact factor: 9.427

9.  Risk factors for complications after performance of ERCP.

Authors:  Jo Vandervoort; Roy M Soetikno; Tony C K Tham; Richard C K Wong; Angelo P Ferrari; Henry Montes; Alfred D Roston; Adam Slivka; David R Lichtenstein; Frederick W Ruymann; Jacques Van Dam; Mike Hughes; David L Carr-Locke
Journal:  Gastrointest Endosc       Date:  2002-11       Impact factor: 9.427

Review 10.  Incidence rates of post-ERCP complications: a systematic survey of prospective studies.

Authors:  Angelo Andriulli; Silvano Loperfido; Grazia Napolitano; Grazia Niro; Maria Rosa Valvano; Fulvio Spirito; Alberto Pilotto; Rosario Forlano
Journal:  Am J Gastroenterol       Date:  2007-05-17       Impact factor: 10.864

View more
  3 in total

1.  Measuring trainee competence in performing endoscopic retrograde cholangiopancreatography: A systematic review of the literature.

Authors:  Theodor Voiosu; Paul Bălănescu; Andrei Voiosu; Andreea Benguş; Carmen Preda; Devica S Umans; Radu Bogdan Mateescu; Jeanin E van Hooft
Journal:  United European Gastroenterol J       Date:  2018-11-28       Impact factor: 4.623

2.  Quality matters: A protocol-based strategy in ERCP training.

Authors:  Brian S Lim
Journal:  J Interv Gastroenterol       Date:  2012-04-01

3.  What Would Be the Appropriate Number of Clinical ERCP Cases for Trainees to Acquire Basic Competence? A Systematic Review and Meta-Analysis.

Authors:  Wenkang Fu; Joseph Leung; Yudong Wang; Tang-Wei Chuang; Wei-Chih Liao; Wenbo Meng; Wence Zhou; Xun Li
Journal:  Turk J Gastroenterol       Date:  2021-01       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.